| Martha Diane Baker, DDS | |
|
6545 France Ave S, Suite 571, Edina, MN 55435-2131 | |
| (952) 926-7696 | |
| Not Available |
| Full Name | Martha Diane Baker |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 6545 France Ave S, Edina, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053351130 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 10114 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Martha Diane Baker, DDS 6545 France Ave S, Suite 571, Edina, MN 55435-2131 Ph: (952) 926-7696 | Martha Diane Baker, DDS 6545 France Ave S, Suite 571, Edina, MN 55435-2131 Ph: (952) 926-7696 |
News Archive
Nature has many examples of self-assembly, and bioengineers are interested in copying or manipulating these systems to create useful new materials or devices. Amyloid proteins, for example, can self-assemble into the tangled plaques associated with Alzheimer's disease - but similar proteins can also form very useful materials, such as spider silk, or biofilms around living cells.
Clear Choice Health Plans, Inc. (OTCBB:CCHN) announced that the company and Adaptis, Inc., its business process outsourcing (BPO) vendor, have mutually agreed to terminate their business relationship and that the Company has entered into a five-year contract for BPO services with The TriZetto Group, Inc., an information technology and services company focused on the health care industry.
According to a new report by iData Research, the leading authority in medical device and pharmaceutical market research, the U.S. peripheral vascular device market is worth $2.8 billion with expected growth to over $5.3 billion by 2016. Increased detection and treatment of abdominal aortic aneurysms (AAAs) and peripheral arterial disease (PAD) are the main drivers of this market, particularly in the stent-graft and peripheral vascular stent segments. These markets are both expected to exceed $1 billion by 2016.
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
› Verified 5 days ago
Steven T Maroney, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 5100 Eden Ave, #209, Edina, MN 55436 Phone: 952-929-0641 Fax: 952-929-1802 | |
Dr. Michele Ann Reynolds, D.D.S.,M.S. Dentist Medicare: Medicare Enrolled Practice Location: 6545 France Ave S, Suite 665 Southdale Medical Building, Edina, MN 55435 Phone: 952-927-8694 | |
Dr. Janet Amy Zingale, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 3930 Sunnyside Rd, Edina, MN 55424 Phone: 952-929-9131 | |
Dr. David John Clay, DDS MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 6545 France Ave S, Suite 680, Edina, MN 55435 Phone: 952-922-5326 Fax: 952-922-5367 | |
Robert Luther Bodin, Dentist Medicare: Not Enrolled in Medicare Practice Location: 5100 Eden Ave, Edina, MN 55436 Phone: 952-929-0641 | |
Dr. Mary Elizabeth Johnson, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 6545 France Ave S, Suite 665, Edina, MN 55435 Phone: 952-927-8694 Fax: 952-927-8695 | |
Dr. Craig Freeman, DDS Dentist Medicare: Medicare Enrolled Practice Location: 7373 France Ave S Ste 500, Edina, MN 55435 Phone: 952-831-2800 |